Metraipolis › archive › dc_852d5cc2fe66

Strengthening health technology assessment for cancer treatments in Europe by integrating causal inference and target trial emulation — Europe PMC PMID:40255411

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40255411
DOI
10.1016/j.lanepe.2025.101294
License (as archived)
solo-consultazione
Archived
2026-10-07T17:19:07.869Z
SHA-256 of the archived text
fb2569fc77d2c33cec8fab1a04a476ee0b8741679205e27d03f47a3c05168b05
Stable URL of this page
https://metraipolis.com/documento/dc_852d5cc2fe66

How to cite

Strengthening health technology assessment for cancer treatments in Europe by integrating causal inference and target trial emulation — Europe PMC PMID:40255411 — Europe PMC (en), https://europepmc.org/article/MED/40255411 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_852d5cc2fe66 (Metraipolis archive dc_852d5cc2fe66, sha256 fb2569fc77d2c33cec8fab1a04a476ee0b8741679205e27d03f47a3c05168b05)
BibTeX
@misc{dc852d5cc2fe66,
  title = {Strengthening health technology assessment for cancer treatments in Europe by integrating causal inference and target trial emulation — Europe PMC PMID:40255411},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40255411},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_852d5cc2fe66; sha256 fb2569fc77d2c33cec8fab1a04a476ee0b8741679205e27d03f47a3c05168b05},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40255411. Agents can read the archived copy with the MCP tool read_document.